Linked Life Data

18654608

Source:http://linkedlifedata.com/resource/pubmed/id/18654608

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18654608rdf:typepubmed:Citationlld:pubmed
pubmed-article:18654608lifeskim:mentionsumls-concept:C0006142lld:lifeskim
pubmed-article:18654608lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:18654608lifeskim:mentionsumls-concept:C0162638lld:lifeskim
pubmed-article:18654608lifeskim:mentionsumls-concept:C0242643lld:lifeskim
pubmed-article:18654608lifeskim:mentionsumls-concept:C0596890lld:lifeskim
pubmed-article:18654608lifeskim:mentionsumls-concept:C1514559lld:lifeskim
pubmed-article:18654608lifeskim:mentionsumls-concept:C0013089lld:lifeskim
pubmed-article:18654608lifeskim:mentionsumls-concept:C0559546lld:lifeskim
pubmed-article:18654608lifeskim:mentionsumls-concept:C1414059lld:lifeskim
pubmed-article:18654608lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:18654608lifeskim:mentionsumls-concept:C0449207lld:lifeskim
pubmed-article:18654608pubmed:issue1lld:pubmed
pubmed-article:18654608pubmed:dateCreated2008-12-16lld:pubmed
pubmed-article:18654608pubmed:abstractTextThe overexpression of reduced expression in immortalized cells (REIC)/Dickkopf-3 (Dkk-3), a tumor suppressor gene, induced apoptosis in human prostatic and testicular cancer cells. The aim of this study is to examine the potential of REIC/Dkk-3 as a therapeutic target against breast cancer. First, the in vitro apoptotic effect of Ad-REIC treatment was investigated in breast cancer cell lines and the adenovirus-mediated overexpression of REIC/Dkk-3 was thus found to lead to apoptotic cell death in a c-Jun-NH(2)-kinase (JNK) phosphorylaion-dependent manner. Moreover, an in vivo apoptotic effect and MCF/Wt tumor growth inhibition were observed in the mouse model after intratumoral Ad-REIC injection. As multidrug resistance (MDR) is a major problem in the chemotherapy of progressive breast cancer, the in vitro effects of Ad-REIC treatment were investigated in terms of the sensitivity of multidrug-resistant MCF7/ADR cells to doxorubicin and of the P-glycoprotein expression. Ad-REIC treatment in MCF7/ADR cells also downregulated P-glycoprotein expresssion through JNK activation, and sensitized its drug resistance against doxorubicin. Therefore, not only apoptosis induction but also the reversal of anticancer drug resistance was achieved using Ad-REIC. We suggest that REIC/Dkk-3 is a novel target for breast cancer treatment and that Ad-REIC might be an attractive agent against drug-resistant cancer in combination with conventional antineoplastic agents.lld:pubmed
pubmed-article:18654608pubmed:languageenglld:pubmed
pubmed-article:18654608pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18654608pubmed:citationSubsetIMlld:pubmed
pubmed-article:18654608pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18654608pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18654608pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18654608pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18654608pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18654608pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18654608pubmed:statusMEDLINElld:pubmed
pubmed-article:18654608pubmed:monthJanlld:pubmed
pubmed-article:18654608pubmed:issn1476-5500lld:pubmed
pubmed-article:18654608pubmed:authorpubmed-author:WatanabeMMlld:pubmed
pubmed-article:18654608pubmed:authorpubmed-author:KawasakiKKlld:pubmed
pubmed-article:18654608pubmed:authorpubmed-author:SakaguchiMMlld:pubmed
pubmed-article:18654608pubmed:authorpubmed-author:NashDDlld:pubmed
pubmed-article:18654608pubmed:authorpubmed-author:KumonHHlld:pubmed
pubmed-article:18654608pubmed:authorpubmed-author:OgasawaraYYlld:pubmed
pubmed-article:18654608pubmed:authorpubmed-author:OchiaiKKlld:pubmed
pubmed-article:18654608pubmed:authorpubmed-author:KashiwakuraYYlld:pubmed
pubmed-article:18654608pubmed:authorpubmed-author:DatiTTlld:pubmed
pubmed-article:18654608pubmed:authorpubmed-author:DoiharaHHlld:pubmed
pubmed-article:18654608pubmed:authorpubmed-author:ZuoZ LZLlld:pubmed
pubmed-article:18654608pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18654608pubmed:volume16lld:pubmed
pubmed-article:18654608pubmed:ownerNLMlld:pubmed
pubmed-article:18654608pubmed:authorsCompleteYlld:pubmed
pubmed-article:18654608pubmed:pagination65-72lld:pubmed
pubmed-article:18654608pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:18654608pubmed:meshHeadingpubmed-meshheading:18654608...lld:pubmed
pubmed-article:18654608pubmed:meshHeadingpubmed-meshheading:18654608...lld:pubmed
pubmed-article:18654608pubmed:meshHeadingpubmed-meshheading:18654608...lld:pubmed
pubmed-article:18654608pubmed:meshHeadingpubmed-meshheading:18654608...lld:pubmed
pubmed-article:18654608pubmed:meshHeadingpubmed-meshheading:18654608...lld:pubmed
pubmed-article:18654608pubmed:meshHeadingpubmed-meshheading:18654608...lld:pubmed
pubmed-article:18654608pubmed:meshHeadingpubmed-meshheading:18654608...lld:pubmed
pubmed-article:18654608pubmed:meshHeadingpubmed-meshheading:18654608...lld:pubmed
pubmed-article:18654608pubmed:meshHeadingpubmed-meshheading:18654608...lld:pubmed
pubmed-article:18654608pubmed:meshHeadingpubmed-meshheading:18654608...lld:pubmed
pubmed-article:18654608pubmed:meshHeadingpubmed-meshheading:18654608...lld:pubmed
pubmed-article:18654608pubmed:meshHeadingpubmed-meshheading:18654608...lld:pubmed
pubmed-article:18654608pubmed:meshHeadingpubmed-meshheading:18654608...lld:pubmed
pubmed-article:18654608pubmed:meshHeadingpubmed-meshheading:18654608...lld:pubmed
pubmed-article:18654608pubmed:meshHeadingpubmed-meshheading:18654608...lld:pubmed
pubmed-article:18654608pubmed:meshHeadingpubmed-meshheading:18654608...lld:pubmed
pubmed-article:18654608pubmed:meshHeadingpubmed-meshheading:18654608...lld:pubmed
pubmed-article:18654608pubmed:meshHeadingpubmed-meshheading:18654608...lld:pubmed
pubmed-article:18654608pubmed:meshHeadingpubmed-meshheading:18654608...lld:pubmed
pubmed-article:18654608pubmed:meshHeadingpubmed-meshheading:18654608...lld:pubmed
pubmed-article:18654608pubmed:year2009lld:pubmed
pubmed-article:18654608pubmed:articleTitleREIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer.lld:pubmed
pubmed-article:18654608pubmed:affiliationDepartment of Cancer and Thoracic Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.lld:pubmed
pubmed-article:18654608pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18654608pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:5243entrezgene:pubmedpubmed-article:18654608lld:entrezgene
entrez-gene:27122entrezgene:pubmedpubmed-article:18654608lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18654608lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18654608lld:entrezgene
lhgdn:association:2962lhgdn:found_inpubmed-article:18654608lld:lhgdn
lhgdn:association:56337lhgdn:found_inpubmed-article:18654608lld:lhgdn
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18654608lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18654608lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18654608lld:pubmed